Debt to EBITDA ratio Analysis of Akero Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of AKRO
Dec-23-0.216Very Poor Debt to EBITDA | Dec-22-0.089Very Poor Debt to EBITDA | Growth-143.07% |
Debt to EBITDA Analysis of Akero Therapeutics Inc
| Debt to EBITDA Ratio of AKRO drastically fell by -143.07 % this year. |
| Debt to EBITDA Ratio with value of 0 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.216 was lowest in Year Dec-23 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.216 is lower than Average Debt to EBITDA of -0.062 in last five years. |
Other Debt to EBITDA Related Info of AKRO that may interest you.
Akero Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| AKRO | 22.91 | 23.98 | 4.46 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of Akero Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.216 | -0.089 | -0.0020 | -0.0037 | 0 | 0 | 0 |
| Change | -143.07 % | -4257.34 % | 45.19 % |
FY Chart of Debt to EBITDA of Akero Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)